Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei Fan

Showing results (1211-1220 of 2,352) with videos related to

Pageof 236
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 3, 2026
Targeting the lactate-lactylation-glucose uptake axis: Cryptotanshinone reprograms metabolic-epigenetic crosstalk in gastric cancerXiaochen Ni, Chuhang Wang, Kaiyuan Zhang, et al.
Frontiers in Medicine|April 17, 2026
Advances in dry eye disease: from immunopathological mechanisms to emerging ophthalmic drug delivery systemsNing Yang, Jiancheng Mu, Feng Xu, et al.
Cell Systems|November 12, 2018
Modeling and Predicting the Activities of Trans-Acting Splicing Factors with Machine LearningMiaowei Mao, Yue Hu, Yun Yang, et al.
Optics Express|February 14, 2023
Investigation on hybrid laser ablation and its application in fused silica damage mitigationLi Zhou, Youen Jiang, Hui Wei, et al.
Haematologica|October 16, 2012
Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human plateletsWei-Fan Chen, Jie-Jen Lee, Chao-Chien Chang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|January 24, 2015
[Regularity of drugs compatibility of anti-hepatoma traditional Chinese medicine ancient prescriptions and risk evaluation of anti-hepatoma new drug research and development]Jing Zhang, Hong-Fa Li, Wei Fan, et al.
The Journal of Surgical Research|September 25, 2021
Partial Latissimus Dorsi Muscle Flap With Implant for Immediate Breast ReconstructionHongmei Zheng, Guodong Zhu, Xiang Li, et al.
BMC Cancer|August 9, 2025
Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system databaseWei Fan Sui, Yu Xin Duan, Ze Feng Cai, et al.
Journal of Hepatocellular Carcinoma|October 20, 2025
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral EradicationWei-Fan Hsu, Ching-Chu Lo, Kuo-Chih Tseng, et al.
Clinical Nuclear Medicine|July 14, 2025
The Prognostic Value of Baseline 18 F-FDG PET/CT in Stage IV Non-Small Cell Lung Cancer Patients Receiving Osimertinib TreatmentZhen-Peng Jiang, Hui-Min Shan, Hao-Yu Zhu, et al.
Pageof 236

Showing results (1211-1220 of 2,352) with videos related to

Sort By:
Pageof 236
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 3, 2026
Targeting the lactate-lactylation-glucose uptake axis: Cryptotanshinone reprograms metabolic-epigenetic crosstalk in gastric cancerXiaochen Ni, Chuhang Wang, Kaiyuan Zhang, et al.
Frontiers in Medicine|April 17, 2026
Advances in dry eye disease: from immunopathological mechanisms to emerging ophthalmic drug delivery systemsNing Yang, Jiancheng Mu, Feng Xu, et al.
Cell Systems|November 12, 2018
Modeling and Predicting the Activities of Trans-Acting Splicing Factors with Machine LearningMiaowei Mao, Yue Hu, Yun Yang, et al.
Optics Express|February 14, 2023
Investigation on hybrid laser ablation and its application in fused silica damage mitigationLi Zhou, Youen Jiang, Hui Wei, et al.
Haematologica|October 16, 2012
Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human plateletsWei-Fan Chen, Jie-Jen Lee, Chao-Chien Chang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|January 24, 2015
[Regularity of drugs compatibility of anti-hepatoma traditional Chinese medicine ancient prescriptions and risk evaluation of anti-hepatoma new drug research and development]Jing Zhang, Hong-Fa Li, Wei Fan, et al.
The Journal of Surgical Research|September 25, 2021
Partial Latissimus Dorsi Muscle Flap With Implant for Immediate Breast ReconstructionHongmei Zheng, Guodong Zhu, Xiang Li, et al.
BMC Cancer|August 9, 2025
Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system databaseWei Fan Sui, Yu Xin Duan, Ze Feng Cai, et al.
Journal of Hepatocellular Carcinoma|October 20, 2025
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral EradicationWei-Fan Hsu, Ching-Chu Lo, Kuo-Chih Tseng, et al.
Clinical Nuclear Medicine|July 14, 2025
The Prognostic Value of Baseline 18 F-FDG PET/CT in Stage IV Non-Small Cell Lung Cancer Patients Receiving Osimertinib TreatmentZhen-Peng Jiang, Hui-Min Shan, Hao-Yu Zhu, et al.
Pageof 236